This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignees: Choongwae Pharma Corporation, Jw Pharmaceutical Corporation. Active years: 2011-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011-2015
Title: Myoung-Joo Kang: Innovator in Medicinal Chemistry
Introduction
Myoung-Joo Kang is a notable inventor based in Hwaseong-si, South Korea. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that have potential therapeutic applications.
Latest Patents
Myoung-Joo Kang holds 2 patents that focus on innovative compounds for treating serious diseases. His latest patents include a "Compound of a reverse-turn mimetic and a production method and use therefor," which relates to novel compounds designed to treat diseases such as cancer, specifically acute myeloid leukemia. Another patent, "Compounds of reverse turn mimetics and the use thereof," discloses conformationally constrained compounds that mimic the secondary structure of biologically active peptides and proteins. These compounds have broad utility, including use as diagnostic and therapeutic agents for cancer treatment.
Career Highlights
Throughout his career, Myoung-Joo Kang has worked with prominent companies in the pharmaceutical industry. He has been associated with Choongwae Pharma Corporation and Jw Pharmaceutical Corporation, where he has contributed to the advancement of medicinal chemistry.
Collaborations
Myoung-Joo Kang has collaborated with notable colleagues, including Jae Uk Chung and Kyung-Yun Jung. These collaborations have further enhanced his research and development efforts in the field.
Conclusion
Myoung-Joo Kang is a distinguished inventor whose work in medicinal chemistry has the potential to impact cancer treatment significantly. His innovative patents and collaborations reflect his commitment to advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile